Tag: Fda ruling

Explore our medication guides and pharmacology articles within this category.

Which is safer, phenylephrine or pseudoephedrine? Comparing efficacy, side effects, and FDA findings

Oct 10, 2025 •

3 min read

In a unanimous 2023 vote, an FDA advisory panel concluded that oral phenylephrine is ineffective as a nasal decongestant, despite not raising safety concerns at recommended doses. This decision has reignited the debate: **Which is safer, phenylephrine or pseudoephedrine?** The answer depends on a nuanced understanding of their efficacy and risk profiles.

Understanding the FDA Ruling: What decongestant was pulled from shelves?

Oct 7, 2025 •

4 min read

In September 2023, an independent advisory committee to the U.S. Food and Drug Administration (FDA) unanimously voted that oral phenylephrine, a long-used decongestant ingredient, is ineffective. This landmark decision led to the voluntary removal of many over-the-counter (OTC) cold and allergy medications, addressing the question of: what decongestant was pulled from shelves?.